[{"Assets_0_Q2_USD":338692000.0,"EarningsPerShareBasic_2_Q2_USD":0.84,"EarningsPerShareBasic_1_Q2_USD":0.54,"EarningsPerShareDiluted_2_Q2_USD":0.77,"EarningsPerShareDiluted_1_Q2_USD":0.49,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":101639000.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":55000.0,"StockholdersEquity_0_Q2_USD":-157356000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":113483000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":113399000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":100739000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":100873000.0,"Ticker":"INVA","CIK":"1080014","name":"INNOVIVA, INC.","OfficialName":"Innoviva Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1257937389.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180726"}]